InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,658.00
(
0.32%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.25
(
0.35%
)
Bitcoin
62,773.78
(
-0.44%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

powerwalker

Send PM Follow Ignore
Followers 45
Posts 6147
Boards Moderated 0
Alias Born 06/17/2009

powerwalker

Re: idcc2006 post# 28203

Tuesday, 06/06/2017 1:54:11 PM

Tuesday, June 06, 2017 1:54:11 PM

Post# of 30990
idcc, what am I wrong about? Knuts mentioned R/A/RC's Nilvad trial and I provided a comment.

I know RC's anatabine is not focused on beta-amyloid. I have mentioned previously that I hope Anavex would use anatabine citrate and its anti-inflammation mechanism with Anavex's 2-73 drug ... I think that would be a real winner against AD and probably other CNS diseases.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up